| 688363 Stock | | | 59.16 1.32 2.28% |
Bloomage Biotechnology financial indicator trend analysis is way more than just evaluating Bloomage Biotechnology prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bloomage Biotechnology is a good investment. Please check the relationship between Bloomage Biotechnology Accounts Payable and its Non Currrent Assets Other accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Accounts Payable vs Non Currrent Assets Other
Accounts Payable vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Bloomage Biotechnology Accounts Payable account and
Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.
The correlation between Bloomage Biotechnology's Accounts Payable and Non Currrent Assets Other is 0.62. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Bloomage Biotechnology Corp, assuming nothing else is changed. The correlation between historical values of Bloomage Biotechnology's Accounts Payable and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Bloomage Biotechnology Corp are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Accounts Payable i.e., Bloomage Biotechnology's Accounts Payable and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.62 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Bloomage Biotechnology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bloomage Biotechnology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Bloomage Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bloomage Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
As of December 1, 2024,
Tax Provision is expected to decline to about 117.2
M. In addition to that,
Selling General Administrative is expected to decline to about 1.5
BBloomage Biotechnology fundamental ratios Correlations
Click cells to compare fundamentals
Bloomage Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bloomage Biotechnology fundamental ratios Accounts
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Balance Sheet is a snapshot of the
financial position of Bloomage Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Bloomage Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bloomage Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bloomage currently owns. An asset can also be divided into two categories, current and non-current.